The Centre has taken a call to not extend indemnity to vaccine developing companies who have got emergency use authorisation for their 'Covaxin' and 'Covishield' jabs. A News18 report said, both Bharat Biotech International Limited and Serum Institute of India will be liable to pay damages. The purchase agreement with these companies says, that they shall be liable for all adversaries as per Central Drugs Standard Control Organisation, the Drugs and Cosmetics Act and DCGI policy. Companies also have to inform the government in case of serious adverse advents. Adar Poonwalla, CEO of Serum Institute, had earlier said that the company needs government to indemnify vaccine makers against all lawsuits. He said that when "frivolous claims crop up and are blown out of proportion, it affects the confidence of not just anti-vaxxers, but the general public too."